English
Vaktsinalar yuqumli kasalliklarning paydo bo'lishi va tarqalishining oldini olish va nazorat qilish uchun juda muhimdir. Odamlarning sog'lig'i haqidagi bilimlarini doimiy ravishda yaxshilash bilan inson vaktsinalariga bo'lgan bozor talabi asta-sekin o'sib bormoqda. Vaktsinalarni ishlab chiqarish va tayyorlash uchun har xil sarf materiallari talab qilinadi, ular orasida cell fabrikalari keng ko'lamli ishlab chiqarishda ajralmas hisoblanadi.
Tegishli ma'lumotlar shuni ko'rsatadiki, vaksinalar paydo bo'lganidan beri emlash 3 million kishining hayotini saqlab qolgan. har yili dunyoda 750 000 bolani nogironlikdan himoya qildi. Mening mamlakatim emlash rejasiga inson qo'llash uchun ba'zi vaktsinalarni ham kiritdi va bolalarni BCG vaktsinasi, gepatit B vaktsinasi, poliomielitga qarshi vaktsina, DTP vaktsinasi, moxovga qarshi vaktsina va boshqalar kabi bepul emlash. Profilaktikada vaksinalarning ajralmasligi tufayli va yuqumli kasalliklarni davolash, ularning bozor talabini e'tiborsiz qoldirib bo'lmaydi. mening mamlakatim odamlar uchun ko'p miqdorda vaktsinalarni import qiladi. Bosh bojxona boshqarmasi ma'lumotlariga ko'ra, Xitoyning 2017-2019 yillarda foydalanish uchun vaktsinalar importi o'sishda davom etdi va 2019 yilda 10,351 milliard yuanga etdi, bu o'tgan yilning shu davriga nisbatan 89,93 foizga o'sdi; 2020 yilning birinchi yarmida u 7,734 milliard yuanga yetdi, bu o'tgan yilning shu davriga nisbatan 43,6 foizga o'sdi. Bu tomonda mamlakatimizda inson vaksinalariga ichki talab kuchli ekanligini ko‘rsatadi.
Vaktsinalarni ishlab chiqarish jarayoni urug‘lik banklarini tashkil etish, yetishtirish, yig‘ish, tozalash, partiyalarni to‘ldirish, qadoqlash va hokazolarni o‘z ichiga oladi. Hujayra zavodi ko‘p -hujayra madaniyati sarf materiallari qatlam tuzilishi. Umumiy spetsifikatsiyalar 1 qatlamli, 2 qatlamli, 5 qatlamli, 10 qatlamli, 40 qatlamli, ishchi kuchi, moddiy resurslar, makon va boshqalarni tejashning afzalliklariga ega va u kamroq ifloslanish bilan mutanosib ravishda kengayish uchun qulaydir. , va vaktsinalarni keng miqyosda tayyorlashda muhim rol o'ynaydi.
Hozirgi vaqtda hujayra zavodi asosan gepatit A vaktsinasida, suvchechak vaksinasida, moxov va parotitga qarshi emlashda, poliomielitga qarshi emlashda, buyrak sindromi vaktsinasi bilan gemorragik isitmada, gepatit A vaktsinasi, gerpes zoster virusiga qarshi emlash, rotavirus vaktsinasi, o'rmon ensefaliti vaktsinasi, quturgan vaktsina Virus, odam grippiga qarshi vaktsina va eritropoetin kabi vaktsinalarni tayyorlash. Hozirgi vaqtda yangi toj virusi avj olmoqda, aholi o'zlarining sog'liq muammolariga ko'proq e'tibor berishadi va vaktsinalarga bo'lgan bozor talabi o'sishda davom etmoqda. Kelajakda mening mamlakatimda inson vaktsinalariga bo'lgan bozor talabi kengayib borishi kutilmoqda va shu bilan hujayra zavodlariga bozor talabini kuchaytiradi.
The FAI climbed 5.9 percent year-on-year in the first 11 months of 2018, quickening from the 5.7-percent growth in Jan-Oct, the National Bureau of Statistics (NBS) said Friday in an online statement.
The key indicator of investment, dubbed a major growth driver, hit the bottom in August and has since started to rebound steadily.
In the face of emerging economic challenges home and abroad, China has stepped up efforts to stabilize investment, in particular rolling out measures to motivate private investors and channel funds into infrastructure.
Friday's data showed private investment, accounting for more than 60 percent of the total FAI, expanded by a brisk 8.7 percent.
NBS spokesperson Mao Shengyong said funds into weak economic links registered rapid increases as investment in environmental protection and agriculture jumped 42 percent and 12.5 percent respectively, much faster than the average.
In breakdown, investment in high-tech and equipment manufacturing remained vigorous with 16.1-percent and 11.6-percent increases respectively in the first 11 months. Infrastructure investment gained 3.7 percent, staying flat. Investment in property development rose 9.7 percent, also unchanged.